Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk
Freedom patients at high risk , Boonen 2011:
כל הפוסטים במחקרים ופרסומים
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
Stand Study-Transition from Aledronate: